BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdelzaher WY, Mostafa-hedeab G, Bahaa HA, Mahran A, Atef Fawzy M, Abdel Hafez SMN, Welson NN, Rofaeil RR. Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway. Pharmaceuticals 2022;15:914. [DOI: 10.3390/ph15080914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi J, Wang J, Jia N, Sun Q. A network pharmacology study on mechanism of resveratrol in treating preeclampsia via regulation of AGE-RAGE and HIF-1 signalling pathways. Front Endocrinol (Lausanne) 2022;13:1044775. [PMID: 36686428 DOI: 10.3389/fendo.2022.1044775] [Reference Citation Analysis]
2 Capriglione S, Gulino FA, Latella S, De Felice G, Filippini M, Farinelli M, Martire FG, Viora E. Results of a Five-Year Experience in First Trimester Preeclampsia Screening. JCM 2022;11:4555. [DOI: 10.3390/jcm11154555] [Reference Citation Analysis]